The potential impact of the gut microbiome on SARS-CoV-2 research

The SARS-CoV-2 virus has impacted billions of lives globally and has spurred many scientists to address the biggest questions regarding this novel coronavirus in their research.

Researchers have taken on the initiative to understand the transmission of this virus and host response as well as identify potential future treatments and develop potential future therapies, including vaccines.

In this webinar, we review some of these key areas of research and explore the potential impact that the gut microbiome has on host response to SARS-CoV-2 as well as the efficacy of various immune interventions such as future vaccines.

Learning objectives:

  • Identify key areas of SARS-CoV-2 research
  • Discuss the influence and impact of the microbiome on these research areas
  • Understand the importance of microbiome profiling as a component of disease research


Heesun Shin, PhD

Heesun Shin, PhD, is a Product Manager, Clinical Next-Gen Sequencing Division (CSD) at Thermo Fisher Scientific

Heesun Shin focuses on developing and managing NGS-based products for human health. Her most recent launch was the Ion AmpliSeq Microbiome Health Research Assay. This, along with the recently released Ion Reporter microbiome analysis solution, allows for optimized commensal microbiome profiling. Heesun’s prior roles include positions in the molecular diagnostics industry developing and commercializing genomic clinical diagnostic tests in oncology.

Heesun received her Ph.D. in genomics and molecular biology from Simon Fraser University, BC, Canada, and post-doctoral training in biomarker discovery in organ transplant rejection using NGS platforms at PROOF Centre of Excellence, University of British Columbia.

Fill in the form to view the free on-demand webinar.

(*Indicates a mandatory field)